Thursday, December 12

Healthcare

Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial

09/10/20241 Min Read

beats cancer drug Keytruda latestage lung Mercks soars stock summit trial

Previous ArticleTerns stock jumps as weight loss drug succeeds in early trial

Next Article Eli Lilly taps veteran Lucas Montarce as new CFO (NYSE:LLY)